Vanguard Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Sell |
|
|||||
|
2025
Q1 | $25.8M | Sell |
|
|||||
|
2024
Q4 | $64.4M | Sell |
|
|||||
|
2024
Q3 | $98.7M | Buy |
|
|||||
|
2024
Q2 | $77M | Buy |
|
|||||
|
2024
Q1 | $87M | Buy |
|
|||||
|
2023
Q4 | $65.5M | Sell |
|
|||||
|
2023
Q3 | $102M | Sell |
|
|||||
|
2023
Q2 | $131M | Sell |
|
|||||
|
2023
Q1 | $148M | Buy |
|
|||||
|
2022
Q4 | $149M | Buy |
|
|||||
|
2022
Q3 | $261M | Sell |
|
|||||
|
2022
Q2 | $296M | Sell |
|
|||||
|
2022
Q1 | $371M | Sell |
|
|||||
|
2021
Q4 | $441M | Buy |
|
|||||
|
2021
Q3 | $496M | Buy |
|
|||||
|
2021
Q2 | $348M | Buy |
|
|||||
|
2021
Q1 | $191M | Buy |
|
|||||
|
2020
Q4 | $132M | Buy |
|